文献速递肾小球疾病

RNA可变剪接与多聚腺苷酸化对肾小球滤过屏障的调控

RNA Alternative Splicing and Polyadenylation and Regulation of the Glomerular Filtration Barrier.
PubMed 文献 · J Am Soc Nephrol · 2025-05-21

研究在嘌呤霉素氨基核苷诱导的微小病变病模型和多柔比星诱导的局灶节段性肾小球硬化模型中行RNA测序,发现肾小球基因可变剪接与多聚腺苷酸化改变,涉及足细胞及裂孔隔膜关键组分,反义寡核苷酸可调控紧密连接蛋白1剪接。

要点

  • 肾小球损伤时足细胞及裂孔隔膜组分的mRNA可变剪接与多聚腺苷酸化改变。
  • 反式元件与顺式元件可能调控足细胞损伤时的可变剪接与多聚腺苷酸化。
  • 反义寡核苷酸可调控mRNA加工事件,为肾小球疾病提供潜在RNA治疗策略。

核心结论

  • 肾小球病理生理及滤过屏障破坏与肾小球基因的可变剪接和多聚腺苷酸化相关,其中许多基因是足细胞结构和功能及裂孔隔膜复合体的关键决定因素。

研究设计与样本

  • 研究用嘌呤霉素氨基核苷或多柔比星诱导伴蛋白尿的肾小球损伤,分别模拟人类微小病变病或局灶节段性肾小球硬化,并行RNA测序分析。
  • 通过JunctionSeq和APATrap流程查询差异外显子及多聚腺苷酸化位点使用所致的可变剪接和多聚腺苷酸化事件。

主要发现

  • 在微小病变病和局灶节段性肾小球硬化模型中,分别鉴定出136/71和1875/746个基因存在可变剪接/多聚腺苷酸化改变。
  • 对紧密连接蛋白1(TJP1)/闭锁小带蛋白1(ZO1)和微管相关蛋白整合膜蛋白2b(ITM2B)的可变剪接进行了进一步表征。
  • 分析了裂孔隔膜核心成员NPHS1、NPHS2和NEPH1的可变多聚腺苷酸化,其mRNA近端与远端多聚腺苷酸化位点使用之间可能存在微小RNA结合位点改变。
  • 在这些肾病模型中发现反式调控元件(多聚腺苷酸化及剪接因子)失调。
  • 吡格列酮和GQ-16等降低蛋白尿的有益治疗逆转了许多可变剪接和多聚腺苷酸化事件。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

KEY POINTS: Alternative mRNA processing adds an important layer of transcriptome complexity in podocyte and slit diaphragm components during glomerular injury. Trans-elements and cis-elements may offer potential mechanisms to regulate alternative splicing and polyadenylation during podocyte injury. Antisense oligonucleotides can regulate mRNA processing events, thus offering a potential RNA-based therapeutic strategy to treat glomerular disease. BACKGROUND: Glomerular disease, characterized by podocyte injury and proteinuria, can lead to CKD and kidney failure. We hypothesized that the glomerular pathophysiology is associated with mRNA alternative splicing and polyadenylation of glomerular genes and of critical podocyte and slit diaphragm components that regulate the filtration barrier. METHODS: Glomerular damage, accompanied by proteinuria, was induced by puromycin amino-nucleoside or adriamycin to mimic human minimal change disease or FSGS, respectively, and RNA-seq analyses was performed. Alternatively spliced and polyadenylated events through differential exon and poly(A) site usage were queried in JunctionSeq and APATrap pipelines. These events were further mapped on podocyte and glomerular landscape, analyzed, and modulated for slit diaphragm components, and cis-regulatory and trans-regulatory elements were identified. RESULTS: Altered glomerular mRNA processing by alternative splicing/polyadenylation was identified in 136/71 and 1875/746 genes in minimal change disease and FSGS models, respectively. Transcript annotation and prioritization of significant alternative splicing and polyadenylation identified key events in several podocyte and slit diaphragm genes with novel and established roles. Alternative splicing of critical slit diaphragm components, the tight junction protein 1 (TJP1)/Zona Occludens-1 (ZO1), and microtubule associating protein integral membrane protein 2b (ITM2B) was further characterized. Alternative polyadenylation of core members of the slit diaphragm, NPHS1, NPHS2, and NEPH1, was analyzed with potential alteration of microRNA-binding sites between the proximal versus distal poly (A) site usage in their mRNAs. Concomitantly, dysregulation of trans-regulatory elements (polyadenylation and splicing factors) was discovered in these models of nephropathies. In addition, beneficial proteinuria-reducing treatments, pioglitazone and GQ-16, reversed many alternatively spliced and polyadenylated events. Moreover, Genome-Wide Association Studies (GWAS) single nucleotide polymorphisms as potential cis-regulatory elements were identified in several genes from the human nephrotic syndrome database. Finally, we demonstrated proof-of-concept principle of chemically modified splice-switching oligonucleotides in modulating tight junction protein 1 splicing in podocytes. CONCLUSIONS: Findings from our studies identified that glomerular pathophysiology and disruption of the filtration barrier is associated with alternative splicing and polyadenylation of glomerular genes, many of which are crucial determinants of podocyte structure and function and the slit diaphragm complex. PODCAST: This article contains a podcast at https://dts.podtrac.com/redirect.mp3/www.asn-online.org/media/podcast/JASN/2025_09_04_ASN0000000748.mp3

来源:J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Das MK, Webb A, Yarram M, et al. RNA Alternative Splicing and Polyadenylation and Regulation of the Glomerular Filtration Barrier. J Am Soc Nephrol. 2025. PMID: 40397520. doi:10.1681/ASN.0000000748

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。